September 20–21, 2023
ARMGO presented at 23RD ANNUAL BIOTECH IN EUROPE FORUM in Basel, Switzerland, September 20 – 21, 2023
The ANNUAL BIOTECH IN EUROPE FORUM organized by SACHS ASSOCIATES is a compact meeting of leading investment, pharma, and biotech companies discussing Europe’s Biotech industry. In its 23rd Annual Edition, this global event addressed current pharma trends and the biotech investment landscape. Many experts shared their outlook for the industry for 2024.
ARMGO’s Vice President, Business Development, Hermann-Josef Kaiser, PhD took part in a panel alongside industry experts from Forbion, EQT Life Science, Cardior Pharmaceuticals GmbH, Neurimmune AG, and Bayer AG. The session, ‘The Heart is in Again – Are We Seeing a Renaissance of Cardiovascular & Cardiometabolic Panel’ provided critical insight into the latest wave of innovations and regulatory challenges to develop new therapeutics for heart disease.
In a separate session Hermann also presented ARMGO’s novel small molecule therapeutics, Rycals, as well as an update on the phase 2 clinical trial to treat the life-threatening arrhythmia, Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).
The meeting took place in-person in Basel, Switzerland.
Hermann-Josef Kaiser, PhD, Vice President Business Development